PAEDIATRIC ALTERED CONSCIOUS LEVEL GUIDELINE

HOME

AIMS

SCOPE

CLINICAL QUESTIONS

EVIDENCE-BASED SEARCH

DELPHI PROCESS

RECOMMENDATIONS

COMMENTS

PARTICIPANTS

DRAFT GUIDELINE

 

Scope Module 1

 

Which patients should be included in module one of the guideline?

 

Included in the guideline will be any paediatric patient presenting with or developing an altered conscious level of unknown cause.

 

 

Which patients should be excluded from module one of the guideline?

 

Excluded from the guideline will be those infants presenting immediately after birth and having not yet been discharged from hospital. This excludes infants with neonatal encephalopathy, which encompasses a large number of causes beyond the scope of the guideline.

Also excluded are patients above the age limit for admission to the local paediatric department.

Patients who are being treated for a known cause of their altered conscious level will be excluded from the guideline. This exclusion criteria has been included to filter off some of the causes of altered conscious level which are secondary to traumatic brain injury (e.g. obvious signs of head injury) or systemic illnesses where altered consciousness may be the end stage (e.g. airway obstruction, severe pneumonia, hypovolaemic shock). Providing evidence-based management guidelines for all these causes where altered consciousness is not primarily neurological in origin would create an unusable document in terms of size. However, advice will be included at the beginning of the guideline as to what these causes may be, how they could be picked up in the “Advanced Paediatric Life Support” primary survey and where guidance may be found (e.g. NICE guidelines CG24 “Head injury”). This advice should also address the need to re-examine the guideline if by treating an “obvious” cause the clinical course or recovery is atypical (e.g. a head injury secondary to a fall may have been precipitated due to a primary encephalopathy).

The exact nature of the filtering process for those patients whose altered conscious level is not primarily neurological in origin has not yet been determined.

 

There has been a discussion about whether other symptoms or signs should be included as part of the entry criteria (e.g. focal neurological signs, seizures, altered behaviour) to ensure that the early stages of encephalopathies (altered consciousness due to a primary brain dysfunction) are not missed. However, in a problem-based guideline only one problem or presenting symptom / sign can form the entry criteria. If more than one symptom is included then the guideline becomes unmanageable (as each individual problem would need its own guideline) and it becomes more like a diagnosis-based guideline (the summation of features forms a diagnosis at the beginning of the guideline).

 

The definition of altered consciousness has been left open for the time being until the systematic literature search / formal consensus process has taken place.

 

 

What is the starting point for module one of the guideline?

 

The guideline begins with the recognition that a paediatric patient has attended hospital with an altered conscious level or that a child already in hospital is recognised to develop an altered conscious level.

 

 

What are the end points for module one of the guideline?

 

The guideline will end when first line investigations have been sent, or are requested, and initial treatments have been started within the first hour or so after presentation. Within the first hour very few laboratory results will be back and the treatment options will be limited. The treatment options available for first line staff include anticonvulsants, intubation and ventilation, dextrose infusion, antibiotics, acyclovir, fluid and inotropic support, bicarbonate, and mannitol. More complicated treatments are unlikely to be available within the first hour after presentation, or would not be started until further test results are reviewed (again unlikely to be available within the first hour or so).

Further management decisions will therefore be covered in the second module after further test results are available and second line investigations have been considered.

 

Scope Module 2